Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pitolisant for excessive daytime sleepiness in obstructive sleep apnea patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Obstructive Sleep Apnea

Drugs mentioned

• Pitolisant (pitolisant)

Snippet

Sponsor: Citrine Medicine Limited | Conditions: Excessive Daytime Sleepiness | Phase 3 | Status: COMPLETED